CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 102 filers reported holding CHEMOCENTRYX INC in Q3 2019. The put-call ratio across all filers is 0.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $35,312,000 | +62.8% | 1,425,000 | +64.7% | 2.67% | +60.4% |
| Q1 2022 | $21,686,000 | +48.9% | 865,000 | +116.2% | 1.66% | +92.3% |
| Q4 2021 | $14,564,000 | -66.6% | 400,000 | -52.9% | 0.87% | -10.7% |
| Q1 2021 | $43,554,000 | -41.4% | 850,000 | -29.2% | 0.97% | -45.1% |
| Q4 2020 | $74,304,000 | -17.8% | 1,200,000 | -27.3% | 1.77% | -49.2% |
| Q3 2020 | $90,420,000 | -41.8% | 1,650,000 | -38.9% | 3.48% | -41.3% |
| Q2 2020 | $155,358,000 | +45.9% | 2,700,000 | +1.9% | 5.93% | +19.8% |
| Q1 2020 | $106,478,000 | -14.5% | 2,650,000 | -15.9% | 4.95% | -0.5% |
| Q4 2019 | $124,583,000 | +909.6% | 3,150,000 | +73.1% | 4.97% | +562.1% |
| Q3 2019 | $12,340,000 | -43.9% | 1,820,000 | -23.1% | 0.75% | -40.5% |
| Q2 2019 | $21,997,000 | -37.3% | 2,365,280 | -6.4% | 1.26% | -46.7% |
| Q1 2019 | $35,085,000 | – | 2,525,900 | – | 2.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |